R&D Projects | SRI International

Toggle Menu

R&D Projects

SRI is conducting preclinical development of treatments for diseases such as tuberculosis, West Nile virus, hepatitis, and biodefense pathogens and toxins.
Innovative Science Overcomes Formulation Challenges
Partnering to Advance Therapy for Radiation Exposure
Through a broad range of services for the National Institutes of Health, SRI is accelerating preclinical development of potential therapies for diseases that affect millions of people.